The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BMRN FINANCIAL STATEMENTS

Biomarin Pharmaceutical Inc — balance sheet, income statement and cash flow trends

BMRNBiomarin Pharmaceutical Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B3 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.4 B $Gross Profit2.6 B $ · 76%Operating Income273.3 M $ · 8%Pre-tax Income149.1 M $ · 4%Net Income to Owners73 M $ · 2%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.4 B $+11.2%
Gross Profit2.6 B $+5.6%
Operating Income273.3 M $-64.8%
EBITDA385.7 M $-58.7%
Net Income to Owners73 M $-88.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B10 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets11.7 B
  • Equity6.3 B $54%
  • Current Liabilities1.7 B $14%
  • Long-term Liabilities3.7 B $32%

Key Figures

YoY change
Total Assets11.7 B $+57.2%
Total Liabilities5.4 B $+277.9%
Total Equity6.3 B $+4.9%
Cash & ST Investments874 M $-39.0%
Total Debt4.2 B $+595.9%
Net Debt3.3 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-4 B-2 B0857.1 M $Operating-4.7 B $Investing3.6 B $Financing-340.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow857.1 M $+11.8%
Capital Expenditures124.2 M $+64.9%
Free Cash Flow732.9 M $+6.0%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BMRN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 23, 26. This content is for informational purposes only and is not investment advice.